Weight‑loss drug users slash grocery bills by £400 a year as GLP‑1 use triples
Rapid rise of GLP‑1 use slashes UK grocery bills
The latest Worldpanel by Numerator reveals that households with at least one GLP‑1 user now spend £780 m less on groceries than comparable non‑user homes, equating to a £418 annual saving per household.
GLP‑1 adoption triples to 1.9 million, driving £780 m grocery savings
Use of GLP‑1 drugs such as Mounjaro and Wegovy has surged from 2.3% of UK households in 2024 to 6.3% in 2026 – an increase from 4.1% in 2025. The survey covered more than 11,600 households across Great Britain.
£780 m grocery spend reduction translates to £418 per household
- 1.9 million adults (tripled in two years) now use GLP‑1 drugs.
- 6.3% of GB households include a user, up from 4.1% in 2025 and 2.3% in 2024.
- Total grocery spend fell by £780 m, or £418 per user household.
- 75% of users cut chocolate consumption; 72% cut crisps.
- 54% report fewer cravings; 52% describe their eating as “mindful”.
- 41% stopped the medication in 2026 because of cost.
Retailers and food brands scramble to adapt to GLP‑1‑driven eating habits
Supermarkets are seeing lower pack counts – 299 million fewer grocery packs were bought in February – and a shift toward “weight‑management” aisles, as seen at Ocado. Marks & Spencer launched a “nutrient‑dense” range aimed at lighter‑eating consumers, while manufacturers anticipate demand for smaller portion sizes and GLP‑1‑friendly menu sections.
Future of the UK food market as GLP‑1 users grow
Analysts expect the grocery sector to continue feeling pressure on volume, prompting more tailored product lines and pricing strategies. If the cost barrier remains, the 41% discontinuation rate could curb growth, but ongoing mainstream adoption suggests a lasting re‑configuration of how British consumers shop for food.